The United States Food and Drug Administration (USFDA) had conducted pre-approval inspection at the company's drug formulations facility in Kothur village during the period from March 2 to 6, 2020, Natco Pharma said in a filing to the BSE.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2S4lVI4
via IFTTT
0 comments:
Post a Comment